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Abstract
Background: Post‑operative nausea and vomiting (PONV); early or late, has detrimental effects on surgical patients 
such as surgical wound disruption, esophageal tear and delayed discharge from the post anesthetic care unit. This 
study evaluated the effects of dexamethasone‑metoclopramide (DM) in the prevention of early and late PONV in women 
undergoing myomectomy under subarachnoid block.
Materials and Methods: Following approval from the Research and Ethics Committee of the Hospital, informed 
consent was obtained from each prospective patient. Patients were randomly allocated to either the DM group, 
metoclopramide only (MO) group or dexamethasones only (DO) group using the computer‑generated random numbers 
in sealed envelopes. Immediately after the induction of spinal anesthesia, the DM group received intravenous (i.v.) 
dexamethasone 8 mg and metoclopramide 10 mg, the MO group received metoclopramide 10 mg i.v and the DO group 
received dexamethasone 8 mg i.v. The incidence of early and late PONV formed the primary outcome.
Results: A total of 90 patients, with aged range between 21‑64 years were studied. Dexamethasone alone group had 
the highest incidence of 40% for early but no for late PONV (P = 0.003) Metoclopramide alone group had an incidence 
of 29.97% for early PONV and 26.6% for late PONV. There was reduced incidence of both early and late PONV in the 
DM group, but of lesser magnitude than DO or MO respectively.
Conclusion: Dexamethasone protects against the incidence of late PONV with a minimal effect on early PONV. The 
combination of dexamethasone and metoclopramide had comparable effect on both and of better magnitude than 
metoclopramide alone.
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Introduction
Post‑operative nausea and vomiting (PONV) is a commonly 
reported complication following surgery and anesthesia.[1] Its 
incidence varies from the type of surgical procedure to the 
type of anesthetic technique employed. The incidence of 
PONV following gynecological surgery has been reported to 
be 75‑93%.[2]  For surgery under general anesthesia (GA), 
the incidence of PONV ranges between 25% and 40% 
respectively.[1]
PONV may be classified into early and late PONV. White 
et al.[3] classified PONV into early PONV (0‑24 h) and 
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late PONV (24‑72 h).[3] Using Apfel’s simplified risk 
scoring system,[2] they found that it was predictive of emetic 
symptoms within 24 h. However, there was no correlation 
between the scoring system and late PONV.
Velickovic and Kalezic also found different risk factors 
for early and late PONV.[4] However, they classified 
PONV into early PONV as 0‑2 h and late PONV as 
2‑24 h post‑surgery. Previous history of PONV and 
parathyroid surgery were predictive for early PONV 
while female gender was more predictive for late PONV 
in their study.
Volatile anesthetics were the leading cause of early PONV 
in a study conducted by Apfel et al.[5] Other factors like 
childhood and the use of post‑operative opioids were the 
main predictors of late PONV in their study. From the 
above findings, it can be deduced that different risk factors 
accounted for early and late PONV. A source of concern 
however is the different classification for early and late 
PONV used in these studies.
PONV following spinal anesthesia is related to spinal‑induced 
hypotension, which increases the incidence of PONV.[6] 
Hypotension (systolic blood pressure [SBP] <80 mmHg), 
blocks higher than T5 and the addition of vasoconstrictors 
to local anesthetic for spinal anesthesia have also been found 
to increase the incidence of nausea and vomiting during 
spinal anesthesia.[7]
Dexamethasone  i s  a  s a f e ,  e f f i cac ious [8 ,9] and 
cost‑effective anti‑emetic when compared with other 
conventional anti‑emetic drugs such as metoclopramide 
or ondansetron. It is effective against PONV resulting 
from a wide variety of surgeries such as tonsillectomy, 
thyroidectomy, abdominal hysterectomy, gynecological 
laparoscopy and laparoscopic cholecystectomy.[10] In 
addition, it has been used in combination therapy with 
both serotonin 5‑hydroxytryptamine antagonists and 
droperidol and was shown to increase the anti‑emetic 
efficacy of these drugs when given for prophylaxis against 
PONV.[11]
Nevertheless, the differential effect of dexamethasone on 
early and late PONV remains to be determined in women 
undergoing gynecological surgeries under spinal anesthesia. 
This study therefore aimed to evaluate the effect of 
dexamethasone in the prevention of early and late PONV 
in this group of patient.
Patients and Methods
Study area
University of Benin Teaching Hospital, Benin City at the 
Obstetrics and Gynecology Department of the hospital.
Ethical approval
Approval for the conduct of the study was obtained from the 
hospital’s Ethics Committee. A written informed consent 
was obtained from every prospective patient enlisted for 
the study.
Study design
A prospective, randomized, double‑blind controlled trial 
of dexamethasone alone, dexamethasone‑metoclopramide 
(DM) versus metoclopramide alone as anti‑emetics in 
women undergoing myomectomy under spinal anesthesia. 
Each eligible patient was randomly assigned to either of the 
three groups using computer‑generated random numbers in 
sealed envelopes.
A pre‑hoc power analysis indicated 26 patients per group 
were required to detect a 50% in the incidence of PONV. 
Allowing for subjects lost to protocol violations and drop 
outs, we recruited 90 patients in all.
Study population
American Society of Anesthesiologists (ASA) 1 or 2 female 
patients with age ranges between 21 and 64 years who were 
scheduled for myomectomy under spinal anesthesia were 
recruited for the study.
Exclusion criteria
previous history of PONV, motion sickness or use of 
anti‑emetics or steroid therapy, gastro‑intestinal disease, 
psychiatric illness and substance abuse.
Study protocol
The study medications (DM) were prepared in identical, 
equal volume 5 ml syringes and labeled by the investigator 
who also administered the drugs. An independent person 
who had no knowledge of study drugs observed each patient 
for PONV.
Anesthetic management
Pre‑anesthetic review was done for all eligible patients in 
the ward the night before surgery. Routine investigations 
including full blood count, electrolyte, urea and creatinine, 
urinalysis were all requested for and done. The patients 
were then classified appropriately based on the ASA 
physical status into either ASA 1 or 2. They were all fasted 
overnight from 2200 h to time of procedure. All the patients 
received oral diazepam 10 mg the night before surgery and 
an hour prior to induction of anesthesia as per departmental 
protocol.
Baseline vital signs namely pulse rate (PR), blood pressure, 
respiratory rate, arterial saturation of oxygen (SpO2) were 
taken and recorded using a multi‑parameter monitor (Dash 
4000 G.E) before induction of spinal anesthesia in the 
operating room. Intravenous (i.v) access was secured 
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with a 16 G cannula and 0.9% saline infused at a rate of 
10 ml/kg for preloading the circulation. Spinal anesthesia 
was induced in the sitting position under strict aseptic 
technique with skin preparation with 0.5% chlorhexidine 
and methylated spirit and sterile fenestrated draping. The 
L3/L4 inter‑space was located and the skin was infiltrated 
with 2 ml of 2% lidocaine. A 25 G Quincke spinal needle 
was inserted at the L3/L4 inter‑space and after confirmation 
of correct placement with free flow of cerebrospinal fluid, 
a hyperbaric solution of 0.5% bupivacaine 15 mg (3 ml) 
was injected into the subarachnoid space. Immediately, 
the patient was re‑positioned supine with the head and 
shoulder supported with a pillow to prevent excessive 
rostral spread of the anesthetic. The level of sensory block 
was tested using the gentle pin‑prick method and recorded. 
Thereafter, the blood pressure was monitored every minute 
for 5 min and every 5 min until the end of procedure were 
obtained.
Immediately following the induction of spinal anesthesia, 
the dexamethasone only (DO) group received 8 mg 
dexamethasone i.v, the DM group received i.v. 
dexamethasone 8 mg and i.v. metoclopramide 10 mg and 
the metoclopramide only (MO) alone group received 10 mg 
i.v. metoclopramide.
Intra‑operative vital signs were monitored at regular intervals 
(5‑10 min) using the Dash 4000 G.E multi‑parameter 
monitor as well as any incidence of nausea and vomiting. For 
the purpose of this study, duration of anesthesia was defined 
as the period between the establishment of spinal anesthesia 
and discharge from the recovery room. The incidence of 
PONV was monitored for the 1st 3 h from the beginning 
of surgery and during the stay in the recovery room (early 
PONV) and the next 21 h in the ward (late PONV). 
Duration of surgery was between 60 and 90 min Vital signs, 
PR, blood pressure, SpO2 were continually monitored every 
10 min in the recovery room until discharge to the ward 
(45 ± 15 min). Vital signs monitoring was continued 
in the ward until the end of 1st 24 h after surgery by the 
ward nurses and recorded. Patients were also questioned 
about incidence and severity of PONV in the ward by the 
investigator during the post‑operative visits. Incidence of 
PONV taken as nausea, vomiting and nausea together 
and vomiting in the three groups was noted and recorded. 
Severity of PONV was graded as 0 = No nausea or 
vomiting, 1 = Nausea, no vomiting, 2 = Vomiting 
once and 3 = Two or more episodes of vomiting. Any 
intra‑operative nausea or vomiting was treated with a dose 
of i.v. metoclopramide 10 mg.
Incidences of hypotension (defined as a decrease in blood 
pressure of more than 20‑30% below baseline values) 
were managed by increasing the flow rate of 0.9% saline 
at 7‑10 ml/kg. Where this was not adequate, incremental 
doses of i.v ephedrine in 3 mg aliquots to a total dose of 
range of 15‑30 mg was administered titrated to effect for 
each patient.
Data collection
Pre‑coded and pre‑tested structured‑interview type 
questionnaires were used both pre‑operatively and 
post‑operatively to obtain relevant socio‑demographic data: 
Age, weight, height, educational status, occupation. History 
of types of medication, past medical and surgical history was 
obtained from each patient.
Nausea and vomiting was assessed thus:
Early PONV: Any incidence of PONV 0‑3 h of anesthesia 
and surgery. This was the period starting from the 
intra‑operative period to the recovery and till discharge 
from the post anesthetic care unit.
Late PONV: Incidence of PONV 4‑24 h post‑operatively. 
Patients were observed for nausea and vomiting in the ward 
for the first the 24 h post‑operatively by the ward nurses 
who were informed about the study and by the investigator.
Statistical analysis
Data collected were entered into a proforma and subjected 
to statistical analysis using the Statistical Package for the 
Social Sciences version 16.0. SPSS (Microsoft Corporation 
@2001). Two‑simple independent Student’s t‑test (2‑tailed) 
and ANOVA were used to analyze continuous patient’s 
variables such as age, weight, duration of surgery/anesthesia. 
Chi‑square and Fisher’s exact test were appropriated for 
discreet variables like symptoms of PONV. A P level <0.05 
was taken as being significant.
Results
A total of 90 patients ASA I or II, representing 51.1% and 
48.9% respectively were enrolled for the study, n = 30 for 
each of the three groups namely dexamethasone alone groups, 
metoclopramide alone and combined DM group [Table 1].
All patients in the three groups had comparable 
socio‑demographic characteristics and clinical profiles except 
for the mean age [Table 1]. The mean age for the three 
groups, DM, MO, DO were 39.8 ± 6.4, 37.8 ± 7.9 and 
35.2 ± 4.2 respectively. Patients in the DM group had a higher 
mean age than the other two groups and this is significant 
(P = 0.023). The body mass index for the three groups was 
similar (28.7 ± 5.6, 29.1 ± 4.3 and 29.7 ± 7.7 respectively).
Table 2 shows the intra‑operative clinical variables of the 
study population. The baseline mean PR in beats/min of the 
three groups (the combined DM group, metoclopramide 
group, the dexamethasone group were 85.6 ± 13.5, 
89.8 ± 12.7 and 85.5 ± 16.9 respectively (P = 0.294). 
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The mean SBP and diastolic blood pressure showed 
statistical significance (P = 0.002). Patients who received 
metoclopramide alone group had a mean higher blood 
pressure (140/85 ± 17/10 mmHg) than the ones in the other 
two groups, dexamethasone 130/78 ± 13.89/12.41 mmHg 
and DM 131/76 ± 12.12/9.745 mmHg.
The average total i.v. fluid given for the three groups was similar. 
An average of 3.2 ± 0.7 L of fluid was given to the patients in 
the combined DM group while 3.2 ± 0.8 L and 3.3 ± 0.7 L was 
given to the DM groups respectively (P = 0.903). The estimated 
blood loss (EBL) for the three groups was also not statistically 
significant. For the combined DM group, the average EBL was 
483.3 ± 215.9 ml while for the DM groups were 506 ± 206.7 ml 
and 491.7 ± 218.6 ml respectively P = 0.912.
The incidence of early and late PONV in the dexamethasone 
is as shown in Table 3. 40 had early PONV while none had 
late PONV. Although the incidence of early PONV in the 
dexamethasone alone group was higher than the other two 
groups, however its superior efficacy in the prevention of 
late PONV was clearly demonstrated by preventing late 
PONV (P = 0.003).
On the incidence of PONV among the three patient groups, 
DM group [Figures 1 and 2] had the least incidence of both 
early and late PONV, (3) 10% and (2) 6.7% respectively. 
Metoclopramide alone group had an incidence of (9) 29.9% 
for early PONV and (8) 26.6% for late PONV while the 
DO group had an incidence of (12) 40% for early PONV. 
The overall incidence of early and late PONV in this study 
was similar, i.e. 33.3% and 33.3% respectively. All the cases 
of PONV in the combined group were mild while 10% and 
20% had moderate and severe PONV respectively in the 
metoclopramide group. The reverse was the case in the 
dexamethasone group as 20% had moderate and 10% had 
severe PONV [Table 4].
Table 5 shows the side effect profile of the study drugs. 
Similar number of patients in the study had mild degree of 
sedation (sedation score 1). However 4 patients in the MO 
had a sedation score of 2 compared with 1 patient in the DM 
group who had sedation score of 2 and none in the DO group.
Similarly, almost equal number of patients (10, 12, 12) in the 
three groups respectively had mild hypotension (BP <20% 
of baseline). 12 in both the MO and DO groups while 10 
had mild hypotension in the DM group. More patients (8) 
in the MO group had moderate hypotension (BP <25% 
of baseline (P = 0.337). No patient in the three groups 
had any episode of severe hypotension to necessitate the 
use of a vasopressor.










Age (years) 39.8±6.4 37.8±7.9 35.2±4.2 0.023
Weight (kg) 74.6±12.8 74.6±12.3 78.4±19.1 0.530













28.7±5.6 29.1±4.2 29.7±7.8 0.791
ASA I/II 14/16 16/14 16/14
BMI=Body mass index, ASA= American society of anesthesiologists











PR (b/min) 85.6±13.5 89.8±12.7 85.5±16.9 0.294
SBP (mmHg) 131.0±12.1 140.1±17.8 130.0±13.9 0.002
DBP (mmHg) 76.0±9.7 85.5±10.8 78.3±12.4 0.002
SPO
2
 (%) 98.9±1.1 98.2±1.8 98.5±1.7 0.262
Level of sensory block 
T4 0 16 06
T6 04 05 03 0.000
T8 11 05 07
T10 15 04 14
Total IVF (L) 3.2±0.7 3.2±0.8 3.3±0.8 0.903
Ext. Blood Loss (ml) 483.3±215.9 506.7±206.7 491.7±218.6 0.912
RP=Pulse rate, SBP=Systolic blood pressure, DBP=Diastolic blood pressure, SPO2=Arterial saturation of oxygen
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None of the patients in the MO group complained of 
itching. However, five patients (16.7%) in the DO group 
and three (10%) in the DM group had episodes of itching 
which did not require treatment. None of the patients in the 
MO and DM group had any incidence of jerking movement.
Discussion
The incidence of early (0‑3 h) and late PONV (4‑24 h) 
varied significantly between the three study groups. The 
dexamethasone alone group had the highest incidence of 
early PONV while the combined DM group had the least 
incidence of early PONV. The combined group had the least 
severe PONV, followed by the dexamethasone alone group 
while the metoclopramide alone group had the most severe.
This finding agrees with a similar study that has demonstrated 
the efficacy of dexamethasone in the prevention of late PONV.
[7] Dexamethasone is known to act by reducing inflammatory 
edema and altering central and peripheral responsiveness to 
pro‑emetic compounds such as anesthetics and analgesics. 
It has been established that the effects of steroids are more 
pronounced in late or delayed vomiting than early vomiting.[12] 
This is due to delayed onset of action and longer duration of 
action. This fact has been used in combination therapy in the 
prevention of PONV. Entezariasl et al.[13] in their study found 
that the incidence of nausea with metoclopramide combined 
with dexamethasone was 8% versus 44% with placebo and 
the incidence of vomiting was 0% versus 20% with placebo. 
They concluded that although prophylactic injection of 
10 mg metoclopramide or 8 mg dexamethasone separately 
Table 5: Side effect profile
Side effect Dexamethasone+Metoclopramide (%) Metoclopramide (%) Dexamethasone (%) P value
Sedation
0 18 (60) 16 (53.3) 20 (66.7) 0.222
1 11 (36.7) 10 (33.3) 10 (33.3)
2 01 (3.3) 04 (13.3) 0
3 0 0 0 
Hypotension
Nil 16 (53.3) 10 (33.3) 15 (50) 0.337
Mild 10 (33.3) 12 (40) 12 (40)
Moderate 04 (13.3) 08 (26.7) 03 (10)
Itching
Yes 03 (10) 0 05 (16.7) 0.074
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 Metoclopramide     Dexamethasone
n = 30
No PONV  Late PONV 
Figure 2:Incidence of late post-operative nausea and vomiting in 
each group
Table 3: Incidence of early and late PONV in 
dexamethasone alone group
PONV Yes No P value
Early PONV (0‑3 hrs) 12 (40%) 18 (60%) 0.10
Late PONV (4‑24 hrs) 0 30 0.003
Total 12 48
PONV= Post-operative nausea and vomiting











0 27 (90%) 21 (70) 18 (60)
1 03 0 03 (10)
2 0 03 (10) 06 (20)
3 0 06 (20) 03 (10)
PONV= Post-operative nausea and vomiting
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can decrease the incidence of PONV, the combined use of 
these drugs has a more marked and significant effect. This is 
because while metoclopramide protects against early PONV, 
dexamethasone acts late for the prevention of late PONV.
Different risk factors have been found to account for 
the incidence of early and late PONV. Earlier studies[3‑5] 
revealed that previous history of PONV, Apfel scoring scale, 
parathyroid surgery and volatile anesthetics accounted 
more for early PONV. On the other hand, female gender, 
parathyroid surgery, age (childhood) and the use of opioid 
for post‑operative analgesia were responsible for developing 
late PONV. As a result of this finding, different anti‑emetics 
may be more affective for early and late PONV.
Dexamethasone had the least effect on sedation from this 
study. This will prove beneficial when sedation is undesirable 
in patients undergoing surgery under spinal anesthesia. In a 
report compiled by the Food and Drug Administration,[14] 
out of 50,257 patients who had side effects while receiving 
dexamethasone, 168 (0.33%) had sedation. This was 
found to be duration, sex and age related. Patients on 
dexamethasone for 1‑6 months had the highest incidence 
of sedation (48.8%). More males (62.4%) than females (37. 
6%) and the elderly (>60 years) had more incidence of 
sedation (48%). A single use of dexamethasone as was 
administered in this study would not predispose to sedation. 
Furthermore, the study population in this study was of the 
female gender aged 21‑60 years.
Sign et al.[15] in their study found that i.v dexamethasone 
given for prophylaxis and treatment of PONV may cause 
perineal pain and pruritus of variable intensity in the awake 
patients. They found that more females were affected than 
their male counterpart. They further suggested that the 
pain/pruritus could be reduced or abolished by diluting 
dexamethasone in 50 ml of fluid given over 5‑10 min. 
Another way suggested by their study to achieve this is by 
giving the drug after induction of anesthesia. In our study, 
the incidence of pruritus in the dexamethasone alone group 
was higher than the other two study drugs. This could be 
due to the gender (female) of the study population and the 
attenuating effect of metoclopramide in the combined group.
Mild hypotension was seen in all the three study groups 
in the intra‑operative period. Hypotension is a known 
complication of spinal anesthesia and the fact that similar 
trends were observed in all the three groups meant that 
it was not primarily due to any of the study medications. 
Pusch et al.[16] demonstrated that a maximum decrease in 
SBP >35% during induction of anesthesia is associated 
with an increased incidence of PONV after gynecological 
surgery during general anesthesia. However, the authors did 
not explain whether the blood pressure decrease triggered 
PONV or PONV symptoms influenced hemodynamic 
variables. They nonetheless suggested that the initial 
hemodynamic instability during the induction of anesthesia 
may play a role in the development of PONV. The degree 
of hypotension observed in this study could be attributed to 
the spinal anesthesia given to all the patients. Furthermore, 
because the hypotension in this study was mild, its role in 
the development of PONV could be negligible.
Post‑operative pain has been recognized as one of the 
predisposing factors to PONV alongside anesthetic 
technique. [1,17,18] However, all the patient groups in the study 
had a similar surgical procedure under the same anesthetic 
technique. This served to reduce the impact of post‑operative 
pain on the incidence of PONV. Despite this fact, i.v. 
administration of dexamethasone had been found to enhance 
the analgesic effect of intrathecal pethidine and reduced the 
incidence of PONV.[19,20] By so doing, dexamethasone could 
have also contributed in reducing the impact of post‑operative 
pain on the incidence of late POVN in these patients.
A limitation to the interpretation of our results is the 
non‑inclusion of control group. For clinical equipoise, it was 
not necessary to offer a placebo when the standard of care 
in the center is the use of metoclopramide. Nonetheless, 
the demonstration of the effect of dexamethasone on late 
PONV underscores the strength of this study irrespective 
of the observable limitations.
Conclusion
Dexamethasone protects against the incidence of late 
PONV without any effect on early PONV. Metoclopramide 
on the other hand has comparable effect on both.
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